Alzheimer’s
Ozempic-Like Drug Slows Cognitive Decline in Mild Alzheimer’s Disease
Posted in Medicine on 27th Aug, 2024
by Alex Muller
In a recent clinical trial involving over 200 participants with mild Alzheimer's, a GLP-1 drug called liraglutide was shown to slow cognitive decline over the course of a year.
Donanemab for Alzheimer's Gets Unanimous Thumbs Up From FDA Panel
Posted in Medicine, Science on 13th Jun, 2024
by Alex Muller
If approved, donanemab will expand the first class of disease-modifying drugs, serving as the building blocks for future generations of drugs.
Researchers developing ultra-sensitive blood test with potential to revolutionise diagnosis of Alzheimer’s
Posted in Medicine, Science on 13th Jun, 2024
by Alex Muller
Researchers at the University of York are using light-based technology to develop a simple and cost-effective blood test for Alzheimer’s disease.
Alzheimer’s risk associated with stressful life events during childhood and midlife, study finds
Posted in Medicine, Science on 22nd Apr, 2024
by Alex Muller
It underscores the potential for early interventions that could target specific life periods to reduce Alzheimer’s disease risk.
Beyond Plaques: New Alzheimer's Treatment Pathway Discovered
Posted in Medicine on 3rd Apr, 2024
by Alex Muller
Researchers have discovered that limiting a certain enzyme can have a dramatic impact in protecting against the effects of Alzheimer's disease.